Grants per year
- 350 - 375 out of 1,104 results
Search results
-
Finished
Northwestern and Jos University Research Training Program in HIV and Malignancies
Murphy, R. L., Achenbach, C. J., Achenbach, C. J., Agulnik, M., Hou, L. & Longnecker, R. M.
John E. Fogarty International Center for Advanced Study in the Health Sciences
5/9/14 → 4/18/19
Project: Research project
-
(PQD5) imaging systemic tissue injuries induced by anticancer drugs
Mazar, A. P., Zhao, M., Rademaker, A. W., Schiltz, G. E., Ugolkov, A., Hou, S. & Mishra, R. K.
5/7/14 → 4/30/19
Project: Research project
-
Mechanisms of hnRNPM in Alternative Splicing Regulation During EMT
Cheng, C.
National Institute of General Medical Sciences
5/1/14 → 5/31/16
Project: Research project
-
ECOG-ACRIN Operations Center (PI Committee)
ECOG-ACRIN Medical Research Foundation, Inc., National Cancer Institute
4/29/14 → 2/28/19
Project: Research project
-
ECOG-ACRIN Nursing Committee
ECOG-ACRIN Medical Research Foundation, Inc., National Cancer Institute
4/29/14 → 2/28/19
Project: Research project
-
Therapeutic Value of PLK1 Knockdown in Combination with Prostate Cancer Drugs in PIM-1 Overexpressing Prostate Cancer Cells
Roh, M.
U.S. Army Medical Research and Materiel Command
4/8/14 → 8/14/14
Project: Research project
-
Prot #AG221-C-001: A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-221 in Subjects with Advanced Hematologic Malignancies with an IDH2 Mutation
INC Research, LLC, Agios Pharmaceuticals, Inc.
4/8/14 → 4/30/21
Project: Research project
-
Treating ovarian cancer with novel ecto-5'nucleotidase (CD73) inhibitors
Marsha Rivkin Center for Ovarian Cancer Research
4/1/14 → 3/31/15
Project: Research project
-
Prot #AC220-007: A Phase 3 Open-Label Randomized Study of Quizartinib (Ac220) Monotherapy versus Salvage Chemotherapy in Subjects with FLT3-ITD Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed After First-Line Treatment With or Without Hema
Novella Clinical, LLC, Ambit Biosciences Corporation
3/25/14 → 3/25/17
Project: Research project
-
Prot #CX-839-003: A Phase 1 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Glutaminase Inhibitor CB-839 in Patients with Relapsed and/or Treatment-Refractory Leukemia
Frankfurt, O.
SCRI Development Innovations, LLC, Calithera Biosciences, Inc.
3/19/14 → 3/19/20
Project: Research project
-
Prot #CA180406: Open-Label Single Arm Phase 2 Study Evaluating Dasatinib Therapy Discontinuation In Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML) With Stable Complete Molecular Response (CMR) DASFREE
ICON Clinical Research, LLC, Bristol-Myers Squibb Company
3/10/14 → 3/10/17
Project: Research project
-
Prot #MEI-005: A Phase II Simon Two-Stage Study of the Addition of Pracinostat to a Hypomethylating Agent (HMA) in Patients with Myelodysplastic Syndrome (MDS) Who Have Failed to Respond or Maintain a Response to the HMA Alone
SCRI Development Innovations, LLC, MEI Pharma, Inc.
3/7/14 → 3/7/17
Project: Research project
-
ECOG-ACRIN Legacy Main Member Support
Frontier Science and Technology Research Foundation, National Cancer Institute
3/1/14 → 8/31/15
Project: Research project
-
Prot #CTKI258AUS26: Modular Phase II Study to Link Targeted Therapy to Patients with Pathway Activated Tumors: Module 2 - Dovitinib for Patients with Tumor Pathway Activations Inhibited by Dovitinib Including Tumors with Mutations or Translocations of FGF
United BioSource LLC, Novartis Pharmaceuticals Corporation
2/14/14 → 12/31/14
Project: Research project
-
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
Cheng, C., Cheng, S. & Siziopikou, K. P.
2/4/14 → 5/31/16
Project: Research project
-
-
The role of emergency granulopoiesis in the pathogenesis of Fanconi Anemia
National Institute of Diabetes and Digestive and Kidney Diseases
2/1/14 → 1/31/19
Project: Research project